Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
journal contribution
posted on 2023-05-21, 23:28authored byCurrie, CJ, McEwan, P, Poole, C, Valentine, WJ, Andrew PalmerAndrew Palmer, Lammert, M, Nicklasson, L, Foos, V, Roze, S
No description available
History
Publication title
Current Medical Research and Opinion
Volume
22
Issue
5
Pagination
967-969
ISSN
0300-7995
Department/School
Menzies Institute for Medical Research
Publisher
Librapharm
Place of publication
C/O Dr. Peter L Clarke, 26-32 Venture West, New Greenham Park, Newbury, England, Berkshire, Rg19 6Hx
Repository Status
Restricted
Socio-economic Objectives
Evaluation of health and support services not elsewhere classified